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EPISPOT: An epigenome-driven approach
for detecting and interpreting hotspots
in molecular QTL studies
Hélène Ruffieux,1,* Benjamin P. Fairfax,2 Isar Nassiri,2 Elena Vigorito,1 Chris Wallace,1,3
Sylvia Richardson,1,4 and Leonardo Bottolo1,4,5SummaryWe present EPISPOT, a fully joint framework which exploits large panels of epigenetic annotations as variant-level information to
enhance molecular quantitative trait locus (QTL) mapping. Thanks to a purpose-built Bayesian inferential algorithm, EPISPOT accom-
modates functional information for both cis and trans actions, including QTL hotspot effects. It effectively couples simultaneous QTL
analysis of thousands of genetic variants and molecular traits with hypothesis-free selection of biologically interpretable annotations
which directly contribute to the QTL effects. This unified, epigenome-aided learning boosts statistical power and sheds light on the reg-
ulatory basis of the uncovered hits; EPISPOT therefore marks an essential step toward improving the challenging detection and func-
tional interpretation of trans-acting genetic variants and hotspots. We illustrate the advantages of EPISPOT in simulations emulating
real-data conditions and in a monocyte expression QTL study, which confirms known hotspots and finds other signals, as well as plau-
sible mechanisms of action. In particular, by highlighting the role of monocyte DNase-I sensitivity sites from >150 epigenetic annota-
tions, we clarify the mediation effects and cell-type specificity of major hotspots close to the lysozyme gene. Our approach forgoes the
daunting and underpowered task of one-annotation-at-a-time enrichment analyses for prioritizing cis and trans QTL hits and is tailored
to any transcriptomic, proteomic, or metabolomic QTL problem. By enabling principled epigenome-driven QTL mapping transcrip-
tome-wide, EPISPOT helps progress toward a better functional understanding of genetic regulation.Introduction
Molecular datasets and annotation databases are growing in
size and in diversity. In particular, genetic data are now
routinely collected along with gene, protein, or metabolite
levelmeasurements and analyzed inmolecular quantitative
trait locus (QTL) studies,with the aimofunravelling the reg-
ulatory mechanisms underlying common diseases. Howev-
er, these studies present additional complexities compared
to classical genome-wide association studies (GWASs). First,
they entail a very different statistical paradigm: while
GWASs consider a single or a few related clinical traits, mo-
lecularQTL studies typically involvehundreds or thousands
of molecular traits, regressed on hundreds of thousands of
genetic variants. Second, they need to accommodate two
types of genetic control: a variant may affect molecular
products of genes in its vicinity (cis action) or products of
remotegenes (trans action),where the lattermodeof control
is typicallymuchweaker and,hence,harder touncover than
the former. In particular, pleiotropic or hotspot genetic var-
iants may exert weak trans effects onmanymolecular traits.
The currentmappingpractice only partially embraces the
features of QTL studies. Indeed, widely used marginal
screening approaches1,2 suffer from a large multiplicity
burden and tend to lack statistical power as they do not
exploit the regulation patterns shared by the molecular1MRC Biostatistics Unit, University of Cambridge, Cambridge CB2 0SR, UK; 2D
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limited by the computational burden implied by the explo-
rationofhigh-dimensional spacesof candidate variants and
traits. To manage this tension between scalable inference
and comprehensive joint modeling, we recently proposed
a variational inference approach, called ATLASQTL,5 which
explicitly borrows information across thousands of molec-
ular traits controlled by shared pathways and offers a robust
fully Bayesian parametrization of hotspots; its increased
sensitivity and that of earlier related models have been
demonstrated in different molecular QTL studies.4–7
In complement to the actual mapping task, biologists
increasingly try to capitalize on the wealth of available
epigenetic annotation sources to infer the functional po-
tential of genetic variants. The standard strategy uses
epigenetic marks mostly for prioritization of hits derived
from marginal screening: it consists in looping through
all the loci with statistically significant associations and,
for each locus, inspecting marks to decide on ‘‘a most
promising’’ functional candidate genetic variant among
all those in linkage disequilibrium (LD). This approach
has the following disadvantages. First, publicly available
databases nowadays contain several hundred epigenetic
annotations. Preselecting just a few may involve omitting
others that are relevant, which may bias the conclusions.
Second, even if a comprehensive inspection were feasible,epartment of Oncology, MRC Weatherall Institute for Molecular Medicine,
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mbridge, Cambridge CB2 0AW, UK; 4The Alan Turing Institute, London
ambridge CB2 0QQ, UK
e American Journal of Human Genetics 108, 1–18, June 3, 2021 1
(http://creativecommons.org/licenses/by/4.0/).
Please cite this article in press as: Ruffieux et al., EPISPOT: An epigenome-driven approach for detecting and interpreting hotspots in mo-
lecular QTL studies, The American Journal of Human Genetics (2021), https://doi.org/10.1016/j.ajhg.2021.04.010the degrees of relevance of the annotations may be very
uneven and may depend on the conditions, cell types, tis-
sues, and even genomic regions considered, so it is unclear
how to weight each contribution. In response to this, a
number of model-based approaches leveraging epigenetic
annotations have been proposed over the past decade,
whether for genome-wide association studies (e.g.,
iBMU,8 bfGWAS,9 FINDOR10) or fine mapping (e.g., PAIN-
TOR,11 RiVIERA12).
Despite this extensive development, no existing method
provides a solution to our problem, namely, modeling the
functional enrichment of trans-QTLs and hotspots, a task
which is substantially more complex and elusive than for
the functional enrichment of cis-QTLs or GWA signals for
a series of related phenotypes. All available modeling tools
are designed for genetic mapping with one8–11 or a few12
traits at a time, while trans-QTL and hotspot mapping re-
quires considering thousands of traits simultaneously.
It is also worth noting that many approaches accommo-
date only small numbers of candidate annotations by
computational or statistical stability constraints,8,9 or
take as input GWA summary statistics rather than individ-
ual-level data, thereby not benefiting from the added sta-
tistical power obtained from jointly modeling the latter,
along with the functional information.10–12
Our work enables large-scale inference for cis- and trans-
QTL regulation using whole panels of external epigenetic
annotations and argues that the epigenome can serve both
to increase statistical power for QTL mapping and to shed
light on the biology underlying the uncovered genetic
map in a systematic manner. Specifically, it couples a fully
BayesianQTLmapping strategy, inwhichall loci andmolec-
ular traits are analyzed jointly, with a principled leveraging
of epigenetic information by treating this information as
complementary predictor-level data that may inform the
probability of genetic variants to be involved in QTL associ-
ations. As successfully demonstrated in the context of ge-
netic mapping with clinical traits, suitable use of epigenetic
information can boost the detection of weak associations
and help in discriminating genuine signals from spurious
ones caused by LD or other confounding factors.13,14
Our modeling framework, called EPISPOT, directly infers
the role of sparse sets of annotations—from hundreds of
candidate functional annotations—in the activation of
both cis and trans mechanisms affecting hundreds to thou-
sands of molecular traits. Importantly, it combines this epi-
genome-driven feature with a flexible hotspot modeling
feature inspired from our previous work,5 thereby offering
a unified toolkit to refine the detection of hotspots, aided
by the epigenetic information at hand. The base version of
EPISPOT assesses the action of the annotations uniformly
for the full set of analyzed transcripts. However, for cases
wherea sensiblepartition intosubsetsof co-expressedmolec-
ular traits (modules15) is available, we also develop amodule
version of EPISPOT, which accommodates module-specific
epigenetic action by estimating the contribution of the
epigenetic marks to the QTL associations in each module.2 The American Journal of Human Genetics 108, 1–18, June 3, 2021Our take is that fully joint modeling is paramount to
borrow information across loci, epigenetic marks, and mo-
lecular traits with complex dependences, but this requires
careful algorithmic considerations to ensure scalable infer-
ence while retaining accuracy. EPISPOT implements an
adaptive and parallel variational expectation-maximiza-
tion (VBEM) algorithm, augmented with a simulated an-
nealing scheme which effectively explores the multimodal
parameter spaces induced by highly structured data. This
optimization routine is purposely tailored to the analysis
of genetic data with strong LD blocks, for which the inclu-
sion of the epigenetic data has the greatest impact.
Our framework also constitutes an effective tool for inter-
preting (1) the detected trans-acting and hotspot variants
based on their overlap with the selected epigenetic marks
and (2) the molecular traits under genetic control in light
of these marks. This additional purpose of EPISPOT is key
given that elucidating themechanismsof actionofhotspots
is often as challenging as mapping them in the first place.
Indeed, there is accumulating evidence that most genetic
variants acting in trans lie in intergenic regions,16–18 where
functional roles are difficult to decipher. Moreover, the
massive trans-gene networks under genetic control are
thought to be subject to subtle interplays, and researchers
are often leftwith a variety of possible strategies to try to un-
derstand the interacting pathways between the genotype
and underlying disease endpoints.19 These strategies range
from hypothesis-driven bottom-up approaches that start
from isolated mechanisms and try to generalize them (e.g.,
based on cis-mediation hypotheses) to agnostic top-down
approaches that directly model the whole system in view
of teasing apart its fundamental components (e.g., based
on graphical modeling approaches).20 Our approach pro-
vides an alternative anchor toward decoding the complex
networks controlled by hotspots, namely via the epigenetic
marks found to be informative for the genetic mapping.
EPISPOT is not targeted at genome-wide discovery but at
effecting refined QTL mapping and hotspot prioritization,
based on genomic regions—hereafter called candidate
loci—harboring SNPs thought to be involved in QTL regu-
lation. A crucial distinction with the existing enrichment
approaches is that the candidate loci do not correspond
to a previously determined list of QTL hits but are whole
genomic regions, which can involve hundreds of genetic
variants (most of them with no QTL activity). EPISPOT ex-
ploits shared epigenetic signals across these regions to then
select QTL hits with an increased statistical power.
Importantly, fruitful applications of EPISPOT, which can
successfully decipher part of the molecular regulation ma-
chinery, require problems where the signal-to-noise and
density of epigenetic/QTL signals are sufficient. In this
work, we will describe extensive simulation experiments
to highlight the benefits of using epigenetic information
when available for a panel of regulation scenarios, and
we will question the conditions under which inference is
adequately powered to leverage this information. We will
therefore formulate guidelines for practical use and
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in the simulation experiments.
Another key component of the present paper concerns
illustrating and exploiting the advantages of EPISPOT in
real molecular QTL conditions. We will conduct and discuss
the findings of a thorough monocyte expression QTL
(eQTL) study leveraging a panel of annotations, including
DNase-I sensitivity sites identified in different tissues and
cell types, Ensembl gene annotations, and chromatin state
data from ENCODE. In particular, by pinpointing context-
relevant marks in a hypothesis-free manner, EPISPOT will
allow us to disentangle key mechanisms pertaining to the
lysozyme pleiotropic activity of chromosome 12—an activ-
ity which, although reported in several studies, is so far left
unexplained in terms of its functional and mediation pro-
cesses. Obtaining such evidence without EPISPOT would
involve the daunting task of evaluating the enrichment of
candidate eQTL hits in each individual epigenetic mark;
this would also have no guarantee of success since one-at-
a-time inspection strategies are deprived of the enhanced
statistical power obtained with a unified joint epigenome/
QTL mapping strategy.Material and methods
Two-level hierarchical regression model
We consider a Bayesian model linking three data sources
(Figure 1A) with two levels of hierarchy. The bottom level param-
etrizes the QTL effects and the top level parametrizes the epige-
netic modulations of the primary QTL effects.
Specifically, the bottom level hierarchy uses a series of condi-
tionally independent spike-and-slab regressions to model the
regulation of q molecular traits by p candidate genetic variants
or single-nucleotide polymorphisms (SNPs) for n samples:
y t
bt ; tt  Nn Xbt ; t1t In ; t ¼ 1;.; q;
bst jgst ;s2; tt  gst N 0; s2 t1t
 þ 1 gstð Þd0; s ¼ 1;.; p;
(Equation 1)
where y ¼ ðy1;.; yqÞ is an n3q matrix of centered responses (mo-
lecular traits) and X ¼ ðX1;.;XpÞ is an n3p matrix of centered
candidate predictors for them (SNPs). Here, d0 is the Dirac distribu-
tion and to each regression parameter bst corresponds a binary
latent parameter gst taking value 1 if and only if SNP s is associated
with trait t. Taking the posterior means of the latent parameters gst
then yields marginal posterior probabilities of inclusion (qtl-PPIs,
Figure 1C), prðgst ¼ 1jyÞ, from which Bayesian false discovery rate
(FDR) estimates can be obtained. Moreover, the precision parame-
ters tt and s
2 are assigned diffused Gamma priors.
The top-level hierarchy parametrizes the effects of the epige-
netic marks on the QTL probability of association via a second-
stage probit regression on the probability of effects:
gst jqs; zt ; x  Bernoulli F zt þ qs þVTs x
  
;
qs  N 0; s20s
 
; zt  N n0; t20
 
;
xljrl  rl N 0; s2
 þ 1 rlð Þd0;
rl  Bernoulli ulð Þ; l ¼ 1;.; r;
(Equation 2)Thwhere Fð $Þ is the standard normal cumulative distribution func-
tion and V ¼ ðV1;.;V rÞ is a p3r matrix of (centered) predictor-
level covariates (epigenetic marks). The epigenetic marks therefore
represent external annotations that directly annotate the SNPs,
rather than sample-specific annotations.
Although prior information on the relevance of the marks for
the QTL control can be accommodated if desirable, this is not
required, as the use of a sparse prior on the mark effects x allows
incorporating a large number of marks even though only a frac-
tion may be responsible for genetic activity. In particular, if
none of the marks are relevant, the QTL mapping will not suffer
any bias from modeling the candidate marks (see simulation
studies hereafter). Moreover, similarly as for the QTL effects,
mark selection is easily achieved using posterior probabilities of in-
clusion, prðrl ¼ 1jyÞ, corresponding to the posterior means of the
binary latent inclusion indicators rl (epi-PPIs, Figure 1C). This
typically yields a sparse subset of marks, whose biological interpre-
tationmay help in understanding themechanisms of action of the
SNPs involved in the QTL associations.A parametrization tailored to the detection of hotspots
Inaddition toembedding thepredictor-level regression for the epige-
netic effects, the top-level probitmodel in Equation 2 also decouples
the contributions of the predictors (SNPs) and the responses (molec-
ular traits), namely, by involving a response-specific parameter, zt ,
which adapts to the sparsity level linked with each response yt and
a predictor-specific parameter, qs, which encodes modulations of
the probability of association according to the overall effect of each
predictorXs. Parameter qs has a central role in pleiotropic molecular
QTL settings as it represents the propensity of each predictor to be
associated with multiple responses, i.e., its propensity to be a hot-
spot. Its Gaussian prior specification ensures closed-form updates,
which is critical to the efficiency of the algorithm on large datasets.
It also conveniently permits using a local-scale representation (via
s0s) to prevent overshrinkage of large hotspot signals; see our previ-
ous work on the hierarchical modeling of hotspots, from which
this formulation is borrowed.5
Here, the value of s0s is set by empirical Bayes, and so are the
epigenetic effect hyperparameters ul and s. The values of the hy-
perparameters n0 and t0 are chosen to induce sparsity, by speci-
fying a prior expectation and a prior variance for the number of
predictors associated with each response (supplemental material
and methods).
Hence, the EPISPOT model (Equations 1 and 2) borrows infor-
mation across the three types of entities (epigenetic marks, SNPs,
and molecular traits) in a unified manner, while providing inter-
pretable posterior quantities, in particular qtl-PPIs and epi-PPIs,
for the selection of each type of variable. It leverages the epige-
nome for two complementary purposes: (1) to enhance statistical
power for QTL and hotspot mapping and (2) to shed light on the
biology underlying the genetic control, via the inspection of the
selected marks.A modification for module-specific epigenetic
contributions
The machinery of genetic control is complex and it is unlikely that
the actionof theepigenomeonQTL regulationwill uniformlyaffect
the transcriptome. In particular, different groups ofmolecular traits
may be governed by different functional mechanisms, involving
different sets of epigeneticmarks, todifferent degrees.Whenaparti-
tion into modules of genes (proteins or metabolites for pQTL ore American Journal of Human Genetics 108, 1–18, June 3, 2021 3
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Figure 1. Overview of EPISPOT
(A) Data input. Epigenetic annotations (predictor-level information) V, genetic variants from candidate loci (candidate predictors) X,
molecular traits (responses) y.
(B) Graphical representation for the two-level hierarchical model. The shaded nodes are observed, and the others are inferred. The top-
level regression corresponds to the top plate; the probability of association is decoupled into a trait-specific contribution, zt , a SNP-spe-
cific contribution with a ‘‘hotspot propensity parameter’’ qs and an epigenome-specific contribution, xl, whereV l is the vector gathering
the observations of predictor-level epigenetic covariate l for all candidate SNP predictors Xs, s ¼ 1;.;p. Parameter bst models the effect
between SNPXs and trait yt , and gst and rl are binary latent indicators for the QTL associations and epigeneticmark involvement, respec-
tively. Parameter s models the typical size of QTL effects and t1t models the residual variability of trait yt .
(C) Posterior output. Selection of epigenetic marks with a role in QTL regulation is carried out using the posterior probabilities of inclu-
sion (epi-PPIs), prðrl ¼ 1jyÞ, l ¼ 1;.; r (bottom left) and selection of associated SNP-trait pairs (aided by the marks) is carried out using
the posterior probabilities of inclusion (qtl-PPIs), prðgst ¼ 1jyÞ, s ¼ 1;.; p; t ¼ 1;.; q (bottom right). The hotspot Manhattan plot (top)
reports the number of traits associated with each SNP (‘‘hotspot size’’), after using a selection threshold on the qtl-PPIs (e.g., FDR-based).
(D) EPISPOTworkflow.Candidate loci andmolecular traits areobtained fromapreliminary screeningor fromexistingdatabases and supplied
as input to themethod along with epigenetic marks at the variants harbored by the loci. The algorithm is used with or without the module
option depending onwhether the traits are gathered intomodules or not (M-EPISPOT in gray, resp. EPISPOT in blue). The output consists of
sets of associated variants and traits, QTL hotspots, and epigenetic marks relevant to the primary QTL associations for given significance
thresholds. It is then interpreted to generate mechanistic hypotheses about the functional processes underpinning the QTL associations.
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the analyst, it can be provided as input to the method which will
then infer theannotationeffects in amodule-specific fashion,based
on the following modification of top-level Equation 2:
gst jqm;s; zt ; xm  Bernoulli F zt þ qm;s þVTs xm
  
;
qm;s  N 0; s20m;s
 




rm;l  rm;l N 0; s2m þ 1 rm;l d0;
rm;l  Bernoulli um;lð Þ; l ¼ 1;.; r;
(Equation 3)4 The American Journal of Human Genetics 108, 1–18, June 3, 2021where m˛M is a module of traits, with M a partition of f1;.; qg
and mHt. Parameter xm then represents the epigenetic contribu-
tion of the r marks for the QTL associations involving the traits
from module m. The hotspot parameter qm;s also accounts for
the module structure: it represents the propensity of SNP s to be
associated with few or many traits from module m. This encodes
module-specific pleiotropic levels and also reflects the fact that a
SNP controlling a given trait in a module is more likely to be
also associated with related traits from the samemodule compared
to traits outside the module.
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Equations 1 and 3—is hereafter called M-EPISPOT when an
explicit distinction with the base, module-free version—imple-
menting Equations 1 and 2—is needed.
Different approaches, basedon someprior state of knowledge, on
specific optimizationmethods, or both,will typically yield comple-
mentary definitions of modules. In some instances, there will be
obvious biological reasons backing up the obtained grouping; in
others, no clear partitioning will emerge, in which case the analyst
may choose to use themodule-free version of themodel. As there is
no generic strategy for forming modules, it is important to under-
stand the impact of such choices on inference. In particular, from
a modeling point of view, a given module should ideally comprise
co-regulatedmolecular traits, i.e., traitswith sharedgenetic control,
triggeredby commonepigeneticmechanisms. The top-level regres-
sion (Equation 3) will then represent the possible epigenetic effects
underlying the functional mechanisms in the module, and mod-
ule-specific epi-PPIs will be useful to select the marks involved in
the regulation of each module. In particular, shared signals will
be best leveraged when the molecular traits controlled by a given
SNP belong to a same module. The simulation studies and the
eQTL analysis will provide practical recommendations as well as
analyses of sensitivity to module misspecification.
A scalable purpose-built algorithm
The hierarchical model described above couples two levels of
spike-and-slab regression, which accommodate three large spaces
of SNPs,molecular traits and epigeneticmarks, with possibly thou-
sands of variables each. Careful algorithmic strategies are therefore
critical to ensure that inference is accurate and scalable. To meet
both requirements, we implement an adaptive variational expec-
tation-maximization (VBEM) algorithm and augment it with a
simulated annealing procedure that efficiently explores the highly
multimodal variable spaces formed by data with strong depen-
dence structures.
VBEM algorithms were introduced by Blei et al.21 in the context
of Dirichlet allocation modeling. In short, they iterate between
optimizing empirical Bayes estimates (in our case for the hotspot
propensity and epigenetic effect hyperparameters) and running
a variational algorithm for the remaining parameters, given the
updated empirical Bayes estimates.
We present hereafter the algorithm in its general module-based
form (M-EPISPOT); omitting the index m and taking M ¼ 1 gives
the base version with no module partitioning (EPISPOT).
Let v ¼ ðb; t;g; s2; q; z; x; rÞ denote the parameters for Equations
1 and 3, and let h ¼ ðh1;.;hMÞ denote the second-stagemodel hy-
perparameters, with hm ¼ ðs20m; s2m;umÞ for module m ¼ 1;.;M.




[ ðh; yÞ; (Equation 4)
where [ ðh; yÞ ¼ logpðyjhÞ is the marginal log-likelihood.
Computing Equation 4 analytically for our model would require
high-dimensional integration and thus is infeasible. Our VBEM al-
gorithm circumvents this by coupling the empirical Bayes estima-
tion of the hyperparameter h with a variational inference scheme
that simultaneously infers the model parameter vector v. The pro-
cedure implements alternating optimizations of the variational
lower bound
Lðq;hÞ¼Eq log pðy; vjhÞ  Eq log qðvÞ; (Equation 5)Thwhere qðvÞ is the variational density for pðvjy; bhÞ for a current esti-
mate bh and Eqð $Þ is the expectation with respect to qðvÞ. More pre-
cisely, it initializes the parameter and hyperparameter vectors vð0Þ
and hð0Þ, and alternates between the E-step,
qðtÞ ¼ arg max
q
Lq;hðt1Þ;
using the variational algorithm for obtaining qðtÞ at iteration t, and
the M-step,
hðtÞ ¼ arg max
h
LqðtÞ;h;
until convergence of hðtÞ. In our case, the updates for the M-step
are obtained analytically by setting to zero the first derivative of
LðqðtÞ;hÞ with respect to each component of h. This only requires
computing and differentiating the joint likelihood term
Eqlogpðy; vjhÞ in Equation 5, as the entropy term EqlogqðvÞ is a
function of hðt1Þ and is constant with respect to h.
Variational inference is typically orders of magnitude faster than
classical Markov chain Monte Carlo inference5,6,22 for compari-
sons on GWA and molecular QTL models. Some computational
cost is added for VBEM algorithms as each E-step requires running
the variational algorithm until convergence. Moreover, the two
regression levels of our Equations 1 and 2 or Equations 1 and 3
necessitate the exploration of a very large parameter space, which
is complex and time consuming for any type of inference.
We consider two strategies to overcome this burden. First, we
substantially reduce the runtime of the within-EM variational
runs by using an adaptive stopping criterion, namely, starting
with a large tolerance and dynamically decreasing it according
to the convergence state of the overall EM algorithm. The second
strategy applies to the module version of our algorithm: the spec-
ification in Equation 3 suggests that its hyperparameters may be
estimated reasonably well by restricting the VBEM scheme to sub-
problems corresponding to each module, i.e., applying Equations
1 and 2 to the subsets of responses ym separately for obtaining the
corresponding empirical Bayes estimates hm,m ¼ 1;.;M. In addi-
tion to accelerating hyperparameter estimation for each module
(as the model is much smaller), this has the advantage of allowing
parallelization across modules. Once all module hyperparameters
are estimated, they are inserted into Equations 1and 3 and varia-
tional inference is run on the entire dataset.
Strong posterior multimodality can be induced by dense geno-
typing panels with marked LD structures, whereby the inclusion
of epigenetic information is particularly beneficial to disentangle
the genetic contributions. To robustly infer signals from problems
with strong data dependence structures, we augment all varia-
tional schemes with a simulated annealing routine.23,24 Annealing
introduces a so-called temperature parameter to index the varia-
tional distributions and control the level of separation between
their modes, thereby easing the progression to the global opti-
mum. In practice, we start with a temperature T0 to flatten the pos-
terior distribution and sweep most local modes away, and we then
lower it at each iteration, until the original multimodal distribu-
tion, called the cold distribution, is reached. Finally, to ensure sta-
ble inference, our routine excludes redundant SNPs and marks
(i.e., displaying perfect collinearity with other SNPs/marks) prior
to the run. Moreover, constant marks or marks that concern less
than a given proportion of SNPs (default 5%) are also discarded
before the analysis as insufficiently informative.
A sketch of the algorithm and the full derivation of the annealed
VBEM updates are in the supplemental material andmethods. Thee American Journal of Human Genetics 108, 1–18, June 3, 2021 5
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Cþþ subroutines (see Web Resources). Both the EPISPOT and M-
EPISPOT versions run within seconds to few hours depending
on the numbers of loci, molecular traits, and epigenetic marks
(see the runtime profiling in the supplemental material and
methods). We also provide simulation studies that demonstrate
the robustness of EPISPOT to different degrees of LD and the
benefit of coupling VBEM inference with simulated annealing in
case of strong LD (supplemental material and methods).Recommended use
EPISPOT is a refining tool for the detection and interpretation of
QTL and hotspot effects. It is meant to be used for joint analysis
of preselected genomic regions (candidate loci) and transcripts
believed to be under genetic control (Figure 1D). Different ap-
proaches can be considered to obtain loci of interest. Public data-
bases can be employed to form loci of given size around previously
identified hits, provided this information is available for the con-
dition, tissue, or cell type at hand. An alternative approach is based
on a preliminary application of ATLASQTL5 or another screening
method, ideally on an independent dataset. If no independent da-
taset is available to the analyst, useful research hypotheses may
still be obtained by running the prescreening step on the same da-
taset, prior to running EPISPOT. However, results should then be
considered as exploratory, since this procedure interrogates the
same data twice, which is subject to overfitting.
The effectiveness of EPISPOT for detecting and exploiting the
relevant epigenetic marks for QTL mapping depends on multiple
conditions that have a coordinated effect on statistical power.
The number of loci analyzed must be reasonably large to hope for
the marks to be sufficiently represented at causal loci. These loci
must also be densely genotyped or imputed to ensure that the
causal SNPs, and the epigenetic marks they may fall into, are
included in the analysis. The frequency of each relevant mark
among causal SNPs, as well as the strength of its contribution to
initiating the QTL effects and the quality of the mark annotation
also play a role, as do the degree of co-regulation of traits by the
same SNPs, the sample size of the analyzed dataset, the individual
effect sizes of QTL associations, and the correlation structures
among marks, traits, and SNPs (LD). We examine the impact of
thesedifferentparameters in a seriesof simulationstudiesdescribed
in the results and in the supplemental material and methods.
Were these conditions not sufficiently met for EPISPOT to
borrow information across the loci and learn the mark contribu-
tions, the QTLmapping would not benefit from further level of in-
formation provided by the marks (no mark selected) but it would
nonetheless benefit from the joint analysis of SNPs and traits.
Notably, the sparse modeling of the marks implies that the inclu-
sion of marks, were these insufficiently informative, has no risk of
deteriorating the QTL mapping (see the ‘‘Null scenario’’ section in
the supplemental material and methods); this is a major advan-
tage of our method.Results
Data generation and simulation set-up
The series of simulation studies presented in the next sec-
tions have the dual purpose of (1) illustrating the effective-
ness of EPISPOT in learning from the epigenome when the
epigenetic annotations at hand are sufficiently informative6 The American Journal of Human Genetics 108, 1–18, June 3, 2021(first simulation study), and (2) evaluating the method in
weakly informative scenarios (second simulation study)
or scenarios where the module partition supplied to M-
EPISPOT is misspecified (third simulation study).
We simulate data so as to best emulate molecular QTL
regulation and the role of the epigenome in triggering
this regulation; the general data-generation procedure is
detailed in the supplemental material and methods and
we further tailor it to each simulation experiment in their
dedicated sections. Here, for simplicity, we represent the
presence or absence of a mark at each SNP using a binary
variable. In real case scenarios, all types of continuous an-
notations can be considered without modification since
they are encoded as predictors in the second-level regres-
sion framework employed by EPISPOT, hence with no
distributional assumption.
We use the following terminology when referring to the
simulated association patterns:
d an ‘‘active SNP’’ has at least one association with a
molecular trait
d an ‘‘active locus’’ involves at least one active SNP
d an ‘‘active trait’’ has at least one association with a
SNP
d an ‘‘active module’’ contains at least one trait
involved in QTL associations
d an ‘‘active mark’’ triggers at least one SNP-trait QTL as-
sociation
d the ‘‘hotspot size’’ is the number of traits associated
with a given hotspot SNP.
We benchmark our approach against two representative
state-of-the-art methods for QTL mapping, namely, the
fully joint Bayesian QTL method ATLASQTL,5 which is
also tailored to the modeling of hotspots but does not
accommodate the epigenetic marks, and the widely used
marginal screening approach MATRIXEQTL,2 which tests
each SNP-trait pair one-by-one and does not involve any
epigenetic information.
A first illustration
We first describe the type of posterior output produced by
EPISPOT and its performance in a simple problem where
no modules are involved, i.e., the active epigenetic marks
exert their influence on all associated SNP-trait pairs.
We simulate 32 datasets with an average of 600 molecu-
lar traits, r ¼ 500 candidate epigenetic marks and 60 candi-
date loci, each comprising an average of 20 real SNPs for
413 subjects. These are initial choices are meant to reflect
plausible scenarios encountered in real applications, after
preselecting candidate loci and candidate traits likely to
be controlled by these loci. A subset of 100 SNPs are active
(between 0 and 3 per locus; see Table 1) and their QTL ef-
fects are triggered by r0 ¼ 3 active marks. This is a strong
assumption, which permits a direct illustration of our algo-
rithm in a simple setting but, since it may be unrealistic,
we will only use it as a starting point for the more complex
Table 1. Average number of simulated loci stratified by the number of active SNPs in the first simulation study
Total number of loci 60
Inactive loci 9.1 (2.7)
Loci with 1 active SNP 17.6 (3.9)
Loci with 2 active SNPs 17.6 (2.6)
Loci with 3 active SNPs 15.8 (2.2)
Standard deviations are in parentheses (32 simulated datasets).
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in the context of the simulations, we also generate marks
with positive effects only, i.e., inducing QTL activity and
not repressing it (supplemental material and methods).
Moreover, the large number of candidate marks and the
low number of active marks are used to illustrate the ability
of EPISPOT to discriminate sparse subsets of relevantmarks
fromwhole panels of marks (most of which with no contri-
bution to the QTL effects). The QTL signals are relatively
weak: for any given trait, the cumulated QTL effects are
responsible for at most 25% of its total variance. Many
active SNPs are hotspots; across all 32 replicates, the active
SNPs are associated with a number of traits ranging from 1
(isolated QTL association) to 96 (large hotspot), with an
average of 27 active traits per active SNP.
All these choices will be varied in the subsequent simula-
tion experiments; for an extensive comparison over a grid of
scenarios, see the supplemental material and methods.
Figure 2 shows that EPISPOT could clearly discriminate
the three active marks contributing to the QTL associa-
tions from the remaining r  r0 ¼ 497 inactive marks.
The partial receiver operating characteristic (ROC) curves
also show that it outperforms ATLASQTL in terms of select-
ing associated SNP-trait pairs and hotspots. It is unsurpris-
ing given that ATLASQTL does not use any predictor-level
information, yet it nevertheless confirms that EPISPOTcan
effectively exploit the marks to enhance the estimation of
the primary QTL associations. MATRIXEQTL performs
poorly compared to the two joint approaches EPISPOT
and ATLASQTL, which is expected since, by design, it
does not exploit the shared association signals across traits.
We checked that EPISPOTand ATLASQTL display similar
performance under simulation scenarios with no active
mark: their 95% confidence intervals for the standardized
partial area under the curve (pAUC) overlap, i.e., (0.74,
0.78) and (0.76, 0.79) for ATLASQTL, resp. EPISPOT (sup-
plemental material and methods). This further supports
the observation that the improvement of EPISPOT seen
in Figure 2 is attributable to an effective use of the three
informative marks and not to other intrinsic differences
between the two models; more evidence on this is pro-
vided in the next simulation experiment.
Performance under varying degrees of epigenome
involvement
Effectiveness in QTL mapping is subject to a number of
interdependent factors pertaining to (1) the sparsity ofThthe studied QTL network and magnitude of the QTL ef-
fects, (2) the amount of information contained in the
data at hand, and (3) the ability of the statistical approach
to interrogate the data, i.e., by both leveraging and being
robust to the dependence structures within and across ge-
netic variants and molecular traits. When it comes to ex-
ploiting the epigenome to enhance statistical power, an
additional level of complexity is introduced for deter-
mining the impact of the above factors on the analysis,
and new questions arise as to whether the signal present
in the data is sufficient to inform inference on the location
of the relevant epigenetic marks and of the QTL associa-
tions potentially triggered by these marks.
In the previous simulation experiment, we generated
data under the simplifying assumption that all QTL associ-
ations were induced by the epigenome, and to a degree to
which the relevant marks would be detectable, as evi-
denced by the high epi-PPIs for the active marks and the
power gained from leveraging this signal (Figure 2). Here,
we focus on evaluating how the level of involvement of
the epigenome in QTL activity impacts the detection of
QTL effects and of the marks responsible for these effects.
We consider a series of QTL problems, each generated by
replicates of 32, for a grid of response numbers and degrees
of involvement of the epigenome in activating QTL con-
trol. More precisely, we simulate data with a number of
traits sampled from a Poisson distribution with mean l ¼
200;400;600;800;1000, or 1,600 and 60 loci with 20
SNPs each and involving 100 active SNPs in total. We
vary the proportion of active SNPs whose activity is trig-
gered by epigenetic marks from pepi ¼ 0 (all QTL associa-
tions simulated independently of the action of the epige-
nome) to pepi ¼ 1 (all QTL associations simulated as the
result of the action of the epigenome); see the supple-
mental material and methods for the data-generation de-
tails. The typical pleiotropic pattern simulated is displayed
in Figure 3 for the different choices of pepi and problems
with an average of l ¼ 600 traits.
Figure 3 also shows the performance for the selection of
QTL effects in terms of standardized pAUC. It provides two
separate layers of information: first, it illustrates again how
EPISPOT is able to leverage the epigeneticmarks to improve
QTLmapping, andmore sowhen thenumber of active SNPs
triggeredbythesemarks increases (top tobottomrows) since
EPISPOT is then able to effectively borrow information
across the mark-activated SNPs. This underlines the need







































































































































Figure 2. Performance for selection of epigenetic marks, pairs of associated SNPs and traits, and hotspots
Left: Epi-PPIs for the marks averaged over 32 replicates. The three marks simulated as active are indicated by the triangles. Middle:
Average partial ROC curves for SNP-trait selection with 95% confidence intervals obtained from 32 replicates. EPISPOT is compared
to the joint hotspot-QTL mapping method, ATLASQTL,5 and the univariate screening method, MATRIXEQTL,2 none of which makes
use of the epigenetic marks. Right: idem for the selection of active SNPs (here, mainly hotspots).
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informative about their involvement. It is therefore advised
to use a reasonably large number of loci thought to be active
anddense SNPpanels (e.g., imputed SNPs, see the eQTL case
study section), so the active SNPs are more likely to be
included. Second, it shows that the joint modeling of all
traits permits exploiting shared signals across these traits,
thereby also improving statistical power, as reflected by
the increased pAUCs for problems with larger numbers of
traits in Figure 3. This is particularly true in the presence of
co-regulated molecular traits, a special case of which is the
regulation of these traits by a single hotspot.
Figure 3 also indicates that, when the epigenetic signal is
moderate to large (pepi ¼ 0.4, 0.6, 0.8, or 1), EPISPOT is able
to pick the active epigenetic marks from a large number of
candidate marks, while setting the epi-PPIs of the inactive
marks to zero. However, when the signal is weak (pepi ¼
0.2), the active marks are barely detected, as expected.
Importantly, though, in the null scenario where the epige-
nome plays no role (pepi ¼ 0), modeling the r ¼ 500 inac-
tive marks does not deteriorate the performance (supple-
mental material and methods).
These experiments also suggest that annotations which
are more likely to trigger QTL associations at numerous
causal SNPs, such as cell-type-specific enhancers, could
have increased opportunities to be picked up and lever-
aged. This may imply that the QTLmapping would benefit
more from the use of general annotations than from that
of more specific types of marks, such as ChIP-seq binding
sites of transcription factors, whichmay display a lower de-
gree of sharing between hotspots. Further investigations
on real datasets would need to confirm this. However, as
there is no intrinsic limitation on the number of candidate
annotations supplied to EPISPOT, nothing prevents the
analyst from using both general and more specific annota-
tions, and letting the model select the annotations which
are sufficiently informative.8 The American Journal of Human Genetics 108, 1–18, June 3, 2021Finally, the quality of the mark annotation will have a
similar impactonperformance.Weshow incomplementary
simulations (supplemental material and methods) that
EPISPOT will not take full advantage of the epigenome if
the supplied annotations are of poor quality: the QTLmap-
ping performance declines with the level of noise in the an-
notations, but EPISPOT remains superior to alternative ap-
proaches for which no annotation information is supplied.
We also tested the impact of other data scenarios on the
ability of EPISPOT to detect and utilize the marks for
improving QTL mapping. More precisely, we ran simula-
tions for a grid of configurations, varying: the number of
active SNPs, the average QTL effect sizes, the degree of
co-regulation of the traits and the hotspot sizes; see section
‘‘QTL mapping performance for a grid of simulated data
scenarios’’ of the supplemental material and methods.
These experiments show that (1) these parameters have a
coordinated effect on statistical power, and (2) thanks to
its flexible hierarchical representation, EPISPOT is very
effective at taking advantage of shared functional patterns,
yielding a substantial mapping performance gain.
Inferring module-specific epigenetic action
The simulation experiments presented next focus on eval-
uating M-EPISPOT, i.e., the module version of the algo-
rithm which models module-specific epigenetic effects.
They illustrate how statistical power and interpretability
are enhanced when the structure underlying epigenome-
driven QTL associations is exploited. They also evaluate
the robustness of inference whenmisspecifiedmodule par-
titions are supplied to M-EPISPOT. This is particularly
important given the uncertainty that often surrounds the
definition of modules, as reflected by fact that different
co-expression inferential tools often produce different
module specifications.
We start with a simple example involving 60 concate-
nated loci of average size 40 SNPs and two modules of 50
Figure 3. Performance of EPISPOT for a grid of numbers of traits and proportions pepi of epigenome-driven active SNPs
Left: Standardized pAUCs for the QTL selection performance with 95% confidence intervals. Middle: Simulated hotspot QTL pattern for
problems with an average of 600 traits (first replicate for each value of pepi). The crosses indicate hotspots whose activity is triggered by
the epigenome and the circles indicate hotspots whose activity is independent of the epigenome. Right: Average epi-PPIs, as inferred by
EPISPOT for the simulated scenarios with an average of 600 traits.
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Figure 4. Performance of M-EPISPOT
(A) Simulated scenario with two modules, whereby the first module m1 is contaminated by an increasing number of traits from the sec-
ond module m2. Panel A(1) shows the simulated pleiotropic pattern for one replicate. The gray levels suggest the different QTL effect
strengths of each active SNP (x axis) with the traits (y axis) from modules m1 and m2. The horizontal dotted lines mark the boundary
between m1 and m2 for the misspecified module partitions supplied to M-EPISPOT. Panel A(2) shows the partial ROC curves (with
95% confidence intervals based on 32 replicates) for the QTLmapping performance obtained when supplying the different misspecified
partitions shown in A(1) to M-EPISPOT.
(B) Simulation with five pleiotropic modules. Panel B(1) shows the simulated pattern for the active SNPs of one replicate. Panel B(2)
panel shows the dependence structure of the simulated traits for one replicate. Panel B(3) shows the module-specific average epi-PPIs
for the contribution of the epigenetic marks to the QTL effects. Panel B(4) shows the partial ROC curves for the QTL mapping, with
95% confidence intervals based on 32 replicates.
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largely co-regulated by hotspots whose activity is imput-
able to the epigenome. In the second module (m2), only
few traits are involved in isolated QTL associations, with
no implication of the epigenome. Figure 4A illustrates
the corresponding simulated QTL pattern restricted to
the active SNPs, for the first data replicate. We evaluate
the performance of M-EPISPOT with the following
settings:
1. The oracle case, where we assume the simulated
module partition M ¼ fm1;m2g to be known and
provided it as input to M-EPISPOT;
2. the module-free case, where we perform inference
with the base model EPISPOTwhich does not exploit
the module partition;10 The American Journal of Human Genetics 108, 1–18, June 3, 20213. a series of intermediate cases, where the module
partition supplied to M-EPISPOT is misspecified,
i.e., module m1 is contaminated with 10;20;30 or
40 traits from module m2 (Figure 4A). This mimics
a real data scenario whereby the assignment of
some traits to modules is difficult.
The ROC curves of Figure 4A show that leveraging infor-
mation about the underlying module partition can
improve significantly the detection of QTL effects. They
also confirm the intuition that the impact of misspecified
partitions on performance is a function of the degree of
misspecification: for a given specificity, the power de-
creases smoothly with the number of inactive traits from
module m2 contaminating module m1. From a modeling
point of view, leaving all traits controlled by a same
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tunities to learn the epigenetic contribution to the QTL ac-
tivity by borrowing strength across co-regulated traits. It is
advised to make use of prior information on pleiotropy
when available in order to avoid splitting hotspot-
controlled networks of traits into distinct modules.
The second simulation experiment considers a more
general setting with 5 modules of average size 50. It com-
pares ATLASQTL, EPISPOT, andM-EPISPOTwith the oracle
module partition supplied and M-EPISPOT with a contam-
inated module partition supplied, i.e., where a fifth of the
traits in the simulated modules are randomly re-assigned
to the other modules.
Figure 4B leads to a conclusion similar to that of the pre-
vious example: the idealized scenario of the oracle module
partition provided to M-EPISPOT yields the best perfor-
mance, followed, in order, by the more realistic case of
the contaminated partition, the EPISPOT run (with no
module information) and finally, the ATLASQTL run
which does not make use of any epigenetic information.
Importantly, the fact that themodule-free version EPISPOT
outperforms ATLASQTL indicates that even when the
module structure is not employed, the method is still
able to leverage the epigenome in order to improve the
QTL mapping.
Figure 4B also shows how the marks responsible for the
activation of the different modules are correctly recovered
by M-EPISPOT. An inspection of these separate sets of
marks provides a refined level of interpretability for a mod-
ule-specific understanding of the genetic control. We will
see in the eQTL analysis presented next how this can be
particularly helpful to shed light on themechanistic action
of trans hotspots, when such hotspots are thought to con-
trol gene modules in a context-specific way.
An epigenome-driven monocyte eQTL case study
In this section, we take advantage of EPISPOT in a targeted
eQTL study to refine the detection and characterization of
genetic regulation in monocytes. Specifically, we analyze
two independent datasets with transcript levels measured
in CD14þ monocytes. Our study workflow is described in
Figure 5A: we discover active loci in a prescreening step us-
ing the joint hotspot QTL mapping approach ATLASQTL5
in the first dataset (n ¼ 413 samples25), and we then
leverage the epigenome using EPISPOT in the second data-
set (CEDAR cohort, n ¼ 286 samples26) for an in-depth
analysis of the genetic activity in the preselected loci.
The epigenetic information consists of a panel of 168
annotation variables, compiling DNase-I sensitivity sites
from different tissues and cell types, Ensembl gene annota-
tions, and chromatin state data from ENCODE. These vari-
ables display strong correlation structures within annota-
tion types, as well as within tissues and cell types at a
finer granularity level (Figure 5C). Details about the pre-
screening step, as well as the epigenetic, genetic, and
expression datasets are given in the supplemental material
and methods, and the eQTL associations for the prescreen-Theing and subsequent analyses are listed in Tables S1, S2, S3,
and S4.
In this case study, we concentrate our attention on the
following key finding revealed by the prescreening step:
chromosome 12 is highly pleiotropic, notably around the
gene LYZ (MIM: 153450). This gene encodes lysozyme, a
highly conserved enzyme with peptidoglycan-lytic activity
that is robustly expressed in monocytes. The LYZ locus has
already been reported as pleiotropic using severalmonocyte
datasets,27–29 but its functional role remainsunclear.Wewill
therefore exploit the epigenetic annotations within EPIS-
POT to shed light on themechanisms of action of this locus
as well as of other surrounding cis- and trans-acting loci.
Importantly, while our discussion will mainly concen-
trate on a few pleiotropic loci of interest, EPISPOT will be
applied on a whole collection of loci from chromosome
12, which display QTL signal according to the ATLASQTL
prescreening at 5% FDR. By borrowing strength across all
the loci (learning from hotspot signals, as well as isolated
cis and trans signals), EPISPOTwill infer the epigenetic con-
tributions to the QTL activity of the different regions.
The LYZ-region pleiotropy defines two modules of transcripts
A total of 977 eQTL associations, involving 350 unique
SNPs on chromosome 12 and 430 unique transcripts
genome-wide, were identified at FDR 5% from the AT-
LASQTL prescreening analysis of the first dataset. When
mapped to the CEDAR dataset, the ATLASQTL eQTLs cor-
responded to 195 independent loci, expected to involve
distinct eQTL signals and comprising a total of p ¼ 1,540
SNPs (see Figure 5A and data-preparation details in the sup-
plemental material and methods). As highlighted in the
second simulation study (section ‘‘performance under
varying degrees of epigenome involvement’’), supplying
a dense panel of SNPs (here imputed SNPs) to EPISPOT is
important to ensure a sufficient representation of the rele-
vant epigenetic marks among the analyzed SNPs.
We also mapped the prescreened transcripts to the
CEDAR dataset. The LYZ-region pleiotropy defines two
natural modules of transcripts, based on whether they
are associated with SNPs in the vicinity of LYZ (<1 Mb
from it) or not, and further augmenting these modules
with highly correlated transcripts (supplemental material
and methods). This module partition is driven by the
following biological consideration: the peculiar pleiotropic
QTL activity arising from the LYZ region may be triggered
by specific epigenetic influences, which may differ from
those triggering isolated (scattered) cis or trans effects
outside the LYZ region; to reflect this, the modules are
hereafter referred to as the pleiotropic module and the scat-
tered module, respectively (Figure 5A).
The correlation structure within and across the two
modules supports this partitioning (Figure 5B). Namely, it
indicates a strong co-expression of transcripts within the
pleiotropic module, suggesting a dense network of genes
whose connections may be attributed in large part to the
shared QTL control exerted by the LYZ hotspots.




Figure 5. Overview of the monocyte eQTL case study
(A) Workflow for the monocyte eQTL case study. Candidate loci from chromosome 12 and transcripts are obtained from a preliminary
prescreening in the first dataset25 using the joint eQTLmapping approachATLASQTL5with a permutation-based Bayesian false discovery
rate (FDR) of 5% for selecting pairs of associated SNP-transcript. The analysis is then performed in the second dataset (CEDAR).26 EPISPOT
andM-EPISPOTselect associated SNP-transcript pairs, QTL hotspots, and epigeneticmarks relevant to the primaryQTL associations. This
output is then interpreted as a whole to generate hypotheses about the mechanisms of action underlying these associations.
(B) Correlation of the analyzed transcripts according to their module membership. The ‘‘pleiotropic module’’ displays a strong depen-
dence pattern, reflecting dense connections in the network controlled by the hotspots; the traits in the ‘‘scattered module’’ are mostly
uncorrelated, which is unsurprising given that they are mainly controlled via isolated cis mechanisms.
(C) Correlation of the epigenetic annotations supplied to the method. All variables are binary, except the distance to the closest tran-
scription start site (TSS) which is not included in the heatmap. Only the labels of the marks retained byM-EPISPOTare displayed; a heat-
map with the full labels is provided in the supplemental material and methods. The majority of the marks are DNase-I hypersensitivity
sites (DHSs) in different tissues and cell types. They tend to cluster together on the top left 4/5 of the heatmap, and DHSs in similar tis-
sues and cell types also form subgroups. The remaining marks relate to gene structures and genome segmentation annotations. The la-
bels indicated on the right are in gray and black depending on whether they were selected by M-EPISPOT as relevant for the pleiotropic,
resp. scattered module. The þ and  indicate positive, resp. negative effects of the marks, i.e., their triggering or repressive action on the
primary QTL effects. Their relevance is discussed in the main text and in the supplemental material and methods.
(D) Hotspot sizes (i.e., number of associated transcripts per SNP) as inferred byM-EPISPOT. Only the active SNPs (i.e., associatedwithR 1
transcripts) are displayed. The gray and black colors indicate the module membership of the controlled transcripts. The numbers in pa-
rentheses refer to the discussion of the main text.
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Table 2. Number of hits and replication rates
PRESCREENING CEDAR
(n ¼ 413, p ¼ 28,100, q ¼ 22,827) (n ¼ 286, p ¼ 1,540, q ¼ 474)
ATLASQTL M-EPISPOT EPISPOT ATLASQTL
Nb eQTL associations 977 514 444 337
cis replication (%) 78.2 77.9 77.9
trans replication (%) 55.8 54.9 54.9
Number of eQTL associations discovered by the ATLASQTL prescreening (chromosome 12) and by each of the three (M-EPISPOT, EPISPOT, and ATLASQTL) an-
alyses of the CEDAR data, along with the replication rates for the associations discovered at the prescreening stage. All analyses use an FDR threshold of 5%. The
numbers of samples n, SNPs p, and transcripts q are indicated for each dataset. Full lists of eQTL associations for the different methods are provided in Tables S1, S2,
S3, and S4.
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tend to be involved in isolated QTL effects (most tran-
scripts are controlled by distinct genetic variants).
Overall comparison of methods and replication rates
We next refined our understanding of the eQTL structure
in this region using the CEDAR dataset. To assess the
sensitivity of inference to this module partition, we
compared the results of the module-based algorithm,
M-EPISPOT, with those of the base algorithm, EPISPOT,
i.e., with no module provided as input. Moreover, to
highlight the benefits of using epigenetic information,
we also confronted these two runs with an ATLASQTL
analysis of the same data. We employed the same set-
tings for all three runs to set common grounds for com-
parison. In particular, we used a same permutation-based
Bayesian FDR threshold of 5% for declaring QTL associa-
tions (Figure 5A and supplemental material and
methods). Importantly, the simulated annealing scheme
implemented as part of the EPISPOT algorithm is specif-
ically designed to handle the strong LD structures pre-
sent in the dense SNP panel data and the block correla-
tion structures among transcript levels (Figure 5B) and
epigenetic marks (Figure 5C); an illustration for different
degrees of LD is given in the supplemental material and
methods.
In the CEDAR dataset, the M-EPISPOT analysis of the
two modules (q ¼ 283þ191 transcripts) and the 195 candi-
date loci (p¼ 1,540 SNPs) identified 514 eQTL associations,
involving a total of 267 unique transcripts and 82 unique
loci (Table S2). In terms of independent replication of the
prescreening hits, this corresponds to rates of 78.2% and
55.8% for the cis and trans QTL associations, respectively.
Using ATLASQTL instead of M-EPISPOT on the CEDAR
data yielded 262 unique active transcripts and 80 unique
active loci, with slightly lower cis and trans replication
rates, namely 77.9% and 54.9%, respectively (Table 2, Ta-
ble S4). Similar observations were obtained for EPISPOT
(Table 2, Table S3). Given the well-known difficulty to vali-
date trans effects and the relatively small sample size of the
CEDAR dataset (n ¼ 289), these appreciable independent
replication rates may result from the efficient joint
modeling of all transcripts and SNPs achieved by M-EPIS-
POT, EPISPOT, and ATLASQTL.TheA focus on two susceptibility loci
We next discuss two examples of pleiotropic loci. First, not
only does M-EPISPOT confirm the LYZ pleiotropic activity
(Figure 5D-i), but it also uncovers associations of this locus
with four additional genes compared to the ATLASQTL
run, namely, COPZ1 (MIM: 615472), DPY30 (MIM:
612032), KLHL28, and OSTC (MIM: 619023). The EPISPOT
run (with no module partitioning) reports the exact same
list as ATLASQTL, also missing the above four genes.
The second example is a pleiotropic locus uncovered by
M-EPISPOT and for which only isolated effects were de-
tected at the prescreening stage (Figure 5D-ii). This locus is
located 32 Mb downstream to the LYZ locus and entails a
hotspot of size 52 in the gene body of GNPTAB (MIM:
607840), namely, rs10860784 (r2 ¼ 0:001with the leadhot-
spot rs10784774 of the LYZ locus). The trans network
formed by the controlled transcripts has not been previ-
ously described and neither has any trans-acting effect
involving rs10860784 (up to proxies using r2 > 0:8). How-
ever, rs10860784 is known to be cis-acting on DRAM1
(MIM: 610776) (located 98 Kb downstream) in multiple
tissues,30 an association which M-EPISPOT also confirms
usinga looser FDRof15%.Moreover, theUKBiobankPheG-
WAS also reported31 a strong association between this SNP
and height (MIM: 606255) (p ¼ 1.47 3 1014).
The module-free version EPISPOT run also finds a trans
network for the exact same SNP, yet slightly smaller, as it
involves 31 transcripts at FDR 5%; ATLASQTL finds no
signal. This example suggests that the added value of epige-
nome-driven inference is particularly striking for the detec-
tion of weak trans signals. Indeed, a comparison of the
estimated QTL effects attributable to rs10860784 with
those attributable to LYZ pleiotropic locus (Figure 5D-i)
shows that the former are significantly smaller in magni-
tude compared to the latter (t test p < 2 3 1016).
The selected epigenetic annotations reveal possible genetic
mechanisms of action
The above figures suggest that the M-EPISPOT and EPIS-
POT runs allow for more powerful QTLmapping compared
to ATLASQTL. This probably results from their ability to
leverage the epigenetic marks, as we next discuss.
For each module, M-EPISPOT identifies a subset of epige-
netic annotations with a potential to induce or inhibit theAmerican Journal of Human Genetics 108, 1–18, June 3, 2021 13
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mean of each annotation effect); these annotations are
highlighted in Figure 5C. For instance, DNase-I hypersen-
sitivity sites (DHS) in fibroblasts and epithelial cells of
different tissues tend to promote the QTL effects. Interest-
ingly, DHS in CD14þmonocytes are found to be enhancers
of eQTL effects in both the M-EPISPOT and EPISPOT runs,
with epi-PPI > 0.99. The two runs also estimate a negative
effect of the distance to transcription start sites (TSSs, epi-
PPI > 0.99), in line with the frequently reported decay in
abundance of eQTL signals with the distance to TSS.32
These last two observations are helpful to interpret the un-
covered QTL signals, as we next discuss.
CD14þ cell DHS: Hints to a monocyte-specific pleiotropic ac-
tivity in LYZ
We first focus on the LYZ pleiotropic region. Previous
studies have highlighted distinct lead hotspots around
LYZ,33 yet none provided a functional characterization
that would allow a clear prioritization of one variant over
another. The lead hotspots revealed by the M-EPISPOT
and EPISPOT runs are intergenic variants, rs10784774
(size 154) and rs2168029 (size 109, r2 ¼ 0:89 with
rs10784774; see Figure 5D-i). They differ from the lead hot-
spot flagged by the ATLASQTL run, namely, rs1384 (size
149, r2 ¼ 0:99 with rs10784774). We next examine the
possible biology behind these candidates, starting with
the ATLASQTL top hotspot.
The fact that rs1384 is located within the 30 UTR of LYZ
may suggest a trans action mediated by LYZ. This hypoth-
esis is plausible given that the locus associates with LYZ in
all M-EPISPOT, EPISPOT, and ATLASQTL runs and that
GTEx also reported this cis association in whole blood
and different tissues. Conversely, regressing out the effect
of LYZ on the expression matrix does not explain away
the hotspot effects (the size of the top hotspot in the LYZ
locus is only marginally reduced: 134 versus 154 in the
original M-EPISPOT analysis, supplemental material and
methods). This does not rule out LYZ expression initiating
the formation of the hotspot, but the downstream conse-
quential changes in expression are too complex to simply
regress out in a linear manner, and so only reduced medi-
ation is observed.
The monocyte-specific DHS annotation selected by M-
EPISPOT for the pleiotropic module suggests a comple-
mentary scenario. Namely, the pleiotropic activity of the
locus may be triggered by cell-type-specific enhancers in
open chromatin regions, which are known to be key
players in activating the transcription in trans.34 This hy-
pothesis of monocyte-specific pleiotropy would also
explain why no hotspot was reported so far in cell types
and tissues other than monocytes.25,35 To investigate this
further, we performed an additional enrichment analysis
using the multiple tissue- and cell-type histone modifica-
tion marks of the ENCODE catalog: we found that the
two sets of genes associated with theM-EPISPOT’s lead hot-
spots rs10784774 and rs2168029, respectively, are en-
riched in H3K27ac enhancers, again in CD14þ monocytes14 The American Journal of Human Genetics 108, 1–18, June 3, 2021only, which further supports cell-type-specific activation.
One notable gene in this group is the transcription factor
CREB1 (MIM: 123810), which has previously been sug-
gested as a putative mediator of the LYZ pleiotropic
network.25 Notably, regressing out the effect of CREB1 on
the expression matrix substantially reduces the pleiotropy
of the locus (the size of the top hotspot in the LYZ locus is
36, versus 154 in the original M-EPISPOT analysis). More-
over, the connectivity of the transcript conditional inde-
pendence network is also markedly lower (supplemental
material and methods).
It seems most plausible, however, that the trans-media-
tion effect by CREB1 may be preceded by a cis effect on
LYZ or an isoform-specific effect. This possibility is sup-
ported by a strong divergent allele-specific correlation be-
tween LYZ and CREB1, which we observed when condi-
tioning on the genotype of the lead hotspot rs10784774
(supplemental material and methods). This indicates an
indirect cis-trans-cis mediation of the trans network by
LYZ-mediated CREB1 expression differentially feeding
back onto LYZ, an observation replicated in both datasets
analyzed. Notably, scanning SNP effects on transcription
factor binding motifs identifies putative divergence in
CREB1 binding dependent upon allelic carriage at
rs10784774, in keeping with the allele-specific correlation
observation (supplemental material and methods). While
our analyses of residual values cannot completely resolve
this, such a feedback circuit might explain why the effect
of regressing for CREB1 is greater than the effect of regress-
ing for LYZ. Finally, it has previously been noted that
EP300 (MIM: 602700), a binding partner of CREB1, shows
allelic effect on LYZ expression,25 although this in an
opposing manner to that observed for CREB1 alone, and
importantly, the effect size of the EP300 association is
markedly less than that for CREB1. In total, these observa-
tions lend further weight to allele-specific regulation via
rs10784774, although, given that CREB1 and EP300 may
form components of multi-protein complexes, the fine
mechanistic details of this regulation fall outside the scope
of this publication.
We further explored whether the two sets of genes asso-
ciated with either rs10784774 and rs2168029 were en-
riched in transcription factor binding sites (TFBS) using
the ENCODE data in K562 cells. We found a profound
enrichment of a number of TBFS, including ATF3,
CREB1, and c-Myc (Table S5). The networks of transcrip-
tion factors for rs10784774 and rs2168029 are similar,
indicating conserved regulatory networks, although unlike
with rs10784774, rs2168029 does not overlap a CREB1
binding site and therefore would not be proposed to feed-
back here.
Interestingly, ATF transcription factors are CREB-bind-
ing proteins, in line with the CREB1-mediation hypothe-
sis, but the strong enrichment for many other transcrip-
tion factors suggests that the same loci can be targeted by
different processes and the co-occupancy of these loci in
primary monocytes may resolve this further, although is
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tion between LYZ and CREB1, there is no association be-
tween LYZ and ATF3 expression, so we can discount this
gene playing a role in this genomic circuit. The c-Myc tran-
scription factor is involved in cell division and has broad
transcriptional consequences,36 which is sensible given
the large pleiotropy observed at the LYZ locus, for
rs10784774 and rs2168029. Consistent with this, the UK
Biobank data further reveal strong associations of these
two SNPs with monocyte counts and other myeloid cell
counts.31
Although by no means conclusive, these observations
corroborate the context specificity of the trans effects
controlled by the LYZ locus, and indeed may be more
representative of other unresolved trans loci across the
genome that, while of potential high biological impor-
tance, lack the pleiotropic effect of the LYZ locus. They
also suggest that the epigenome-driven EPISPOT runs
found promising candidate hotspots, whose presumed
mechanisms of action on the massive LYZ gene network
would merit experimental follow up.
Distance to TSSs: Examples of cis and hotspot signals shared
across cell types
Another interesting result concerns the negative effect of
the annotation coding the distance to TSSs, this time for
transcripts belonging to the scattered module. As active
transcripts in this module are mostly involved in cis associ-
ations, the module specificity of this annotation aligns
with the previous observation that the distance to TSSs as-
sociates with an enrichment of cis eQTLs.32,37 Moreover,
an empirical assessment of this enrichment in our dataset
shows that the SNPs selected with M-EPISPOT are on
average significantly closer to TSSs compared to SNP sub-
sets of the same size randomly drawn within the analyzed
loci (p ¼ 0.017). Such an enrichment is unsurprising and
actually also present in the EPISPOT and ATLASQTL re-
sults, but the importance of the distance to TSS is neverthe-
less made explicit by the selection of the TSS variable by
both EPISPOT and M-EPISPOT.
For instance, three candidate hotspots, rs10876864,
rs11171739 (r2 ¼ 0:94 with rs10876864), and rs705699
(r2 ¼ 0:86 with rs10876864), located 13 Mb upstream of
the LYZ locus, are representative of this enrichment as
they are within a TFBS, a 50 UTR and an exon, respectively
(Figure 5D-iii). Our ATLASQTL prescreening and EPISPOT
analyses find that they control a small network of size 11
involving transcripts mapping to the cis gene RPS26
(MIM: 603701) and other distal genes, including IP6K2
(MIM: 606992) on chromosome 3.
This locus has been linked with several autoimmune dis-
eases38–41 including type 1 diabetes (MIM: 222100), where
evidence exists that RPS26 transcription does not mediate
the disease association.42 Interestingly, previous studies
have reported the RPS26 cis effect as an isolated association
in monocytes. The trans activity, in particular on IP6K2,
was unknown in monocytes, but is known in B and
T cells.25,43 This suggests that it has so far gone unnoticedThein monocytes using standard univariate mapping ap-
proaches, but our fully joint, annotation-driven method
has enabled its detection. Moreover, unlike the mono-
cyte-specific LYZ pleiotropic locus discussed above, this lo-
cus is an example of trans-hotspot eQTL present in several
cell types. The genomic location also aligns with the obser-
vation that eQTLs common tomultiple cell types or tissues
tend to be closer to TSSs compared to eQTLs only detect-
able in a single cell type or tissue.44
Discussion
Large panels of epigenetic marks are nowadays collected
along with genetic data and employed as part of different
modeling approaches, whether for single-trait association
studies or fine mapping.8–12 However, their use to enhance
molecular QTL mapping remains mostly heuristic. Thanks
to its hypothesis-free mark selection routine which is fully
integrated within a joint QTL mapping framework, EPIS-
POT can identify the relevant epigenetic marks from thou-
sands of candidates, while also directly refining estimation
in large molecular QTL studies.
Specifically, EPISPOT brings important modeling and
algorithmic contributions. First, it implements a flexible
hierarchical model which enables parametrizing both cis
and trans actions on thousands ofmolecular traits, whereas
existing epigenome-based approaches are limited to GWAS
or cis QTL mapping for one or a handful of traits.8–12 Sec-
ond, it is both fully joint and scalable, accounting for all
epigenetic marks, genetic variants and molecular levels,
and their shared signals, in a single modeling framework.
Third, it combines this information to perform an auto-
mated selection of the epigenetic marks relevant to the
QTL effects of the problem at hand, thereby providing
direct insight into the functional basis of the signals.
Fourth, its crafted annealed variational algorithm ensures
a robust exploration of complex parameters spaces, such
as induced by candidate SNPs in high LD, corresponding
to scenarios for which the use of epigenetic information
is particularly beneficial. Finally, EPISPOT allows for mod-
ule-specific learning of the epigenetic action.
We showed in a series of simulation experiments
emulating epigenome-driven QTL problems that EPISPOT
effectively scales to large datasets, while retaining the accu-
racy necessary for a powerful QTL mapping. We demon-
strated that our method was not only able to pinpoint
the correct marks with high posterior probability, but
that it could also leverage these marks to improve the
detection of weak QTL signals. In particular, we saw that
the spike-and-slab representation of the epigenome contri-
bution ensures that the irrelevant epigenetic marks are
effectively discarded as ‘‘noise,’’ so panels with hundreds
of candidate marks can be considered without the risk of
worsening inferences. This allows skipping the delicate
process of pre-filtering marks, whose practical grounds
are often blurry and disconnected from the QTL dataset
under consideration. Moreover, although in a strict senseAmerican Journal of Human Genetics 108, 1–18, June 3, 2021 15
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tions, it is possible to interpret this terminology more
loosely and supply other types of annotations or scores
that may carry information about the involvement of
SNPs in QTL regulation.
Our work attaches special importance to acknowledging
the complexity of the learning task (selection of hotspots,
pairwise QTL associations between variants and molecular
traits, selection of epigenetic marks relevant to these QTL
associations) and possible biological scenarios (pattern of
regulation, importance of the epigenome in this regula-
tion, dependence structures among variants, marks and
molecular traits, and between them). Our simulations
examined under what conditions inference is well pow-
ered to leverage the epigenetic information and evaluated
the sensitivity to different input choices, in particular
when gene modules are provided. Importantly, our
method is not meant to be used as a black box to fish ge-
netic variants involved in trans regulation and their epige-
netic roots, but rather is predicated on a careful analysis
design that takes into account the dataset, the biological
question of interest, and the expected statistical power.
Further assessments for specific problem settings (sparsity
levels, association patterns, and epigenetic control) can
be made using the code provided online (see EPISPOT
and ECHOSEQ in web resources).
Finally, we showed how our simulation studies prefig-
ured the efficiency of EPISPOT in a large monocyte
eQTL study (high replication in an independent sample,
previously unreported pleiotropic loci, refined list of
candidate lead hotspots). We further illustrated how the
EPISPOT posterior output can be used to both select inter-
pretable annotations underlying the QTL activity and
reduce the range of hypotheses about the functional
mechanisms involved, particularly for hotspots. We also
showed how the localized nature of QTL activity could
be accounted for when inferring annotations in a mod-
ule-specific fashion using M-EPISPOT (the monocyte-spe-
cific enhancer activity affecting the pleiotropic module,
the enrichment of QTL hits closer to TSSs affecting the
scattered module). Altogether, this thorough case study
demonstrates that QTL analyses may largely benefit
from the use of rich complementary data sources anno-
tating the primary genotyping data, provided principled
joint approaches are used to capture shared association
patterns.
EPISPOT offers perspectives for robust and interpretable
molecular QTL mapping, toward a better understanding of
the functional basis of genetic regulation. Thanks to its
efficient annealed VBEM algorithm with adaptive and par-
allel schemes, it enables information sharing across epige-
netic marks, genetic variants, and molecular traits gov-
erned by complex regulatory mechanisms, at scale. In
particular, its use of selection indicators in a spike-and-
slab framework allows for a systematic identification of
sparse sets of epigenetic annotations which are directly
relevant for the QTL regulation of the problem at hand.16 The American Journal of Human Genetics 108, 1–18, June 3, 2021We envision holistic approaches such as EPISPOT to be
increasingly adopted in an age where large molecular data-
sets and annotation information become widely available.
EPISPOT is applicable to any type of molecular QTL prob-
lem, involving genomic, proteomic, lipidomic, or metabo-
lomic levels, but also to genome-wide association with
several clinical endpoints. In particular, exploiting the epi-
genome to build finer maps of hotspots across the genome
holds great promises, as these master regulators are likely
to be triggered by tissue- and cell-type-specific epigenetic
functions.Data and code availability
Fairfax et al.25,28 provide gene expression in CD14þ monocytes
and genotyping data from individuals with European ancestry.
The raw expression data were generated with Illumina Hu-
manHT-12 v4 arrays and downloaded from ArrayExpress45 (acces-
sion E-MTAB-2232), while the raw genotyping data were gener-
ated by Illumina HumanOmniExpress-12 arrays and have been
deposited at the European Genome-Phenome Archive (acces-
sions: EGAD00010000144 and EGAD00010000520). The expres-
sion data are freely available, but the genotyping data require a
data access agreement, as detailed in Fairfax et al.25,28 and
https://www.well.ox.ac.uk/research/research-groups/julian-knight-
group/research-projects/data-access.
The CEDAR dataset26 consists of gene expression data fromCD14þ
monocytes and genotyping data from individuals with European
ancestry. The raw expression data were generated with Illumina
HumanHT-12 v4 arrays and downloaded from ArrayExpress45
(accession: E-MTAB-6667), while the raw genotyping data were
generated by Illumina HumanOmniExpress-12 v1_A arrays and
downloaded from ArrayExpress (accession: E-MTAB-6666). Both
the expression and genotyping data are freely available.
Both studies were approved by the local human research ethic
committees, namely, the Oxfordshire Research Ethics Committee
(COREC reference 06/Q1605/55)28 and the University of Liège Ac-
ademic Hospital Ethics Committee.26 Participants provided
informed written consent, and all procedures were conducted in
accordance with the Declaration of Helsinki.
All statistical analyses were performed using the R environment
(v.3.6.1)46 and the synthetic datasets were generated using the
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